期刊
MOLECULAR PHARMACOLOGY
卷 89, 期 5, 页码 485-491出版社
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.115.102657
关键词
-
资金
- Innovational Research Incentive Scheme of The Netherlands Research Organization [11188]
How drugs dissociate from their targets is largely unknown. We investigated the molecular basis of this process in the adenosine A(2A) receptor (A(2A)R), a prototypical G protein-coupled receptor (GPCR). Through kinetic radioligand binding experiments, we characterized mutant receptors selected based on molecular dynamic simulations of the antagonist ZM241385 dissociating from the A(2A)R. We discovered mutations that dramatically altered the ligand's dissociation rate despite only marginally influencing its binding affinity, demonstrating that even receptor features with little contribution to affinity may prove critical to the dissociation process. Our results also suggest that ZM241385 follows a multistep dissociation pathway, consecutively interacting with distinct receptor regions, a mechanism that may also be common to many other GPCRs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据